Overview

Risk is not distributed evenly, and a small set of genes can mark the people who should be watched most closely. The 10-gene lung risk panel focuses on variants that shift a person's probability of developing lung cancer, helping clinicians stratify populations for earlier or more frequent assessment. This narrower design keeps screening affordable while still capturing the most informative signals.

How It Works

The panel sequences ten genes associated with inherited and somatic lung cancer risk from a single sample, often blood or saliva for germline context. Library preparation uses targeted capture so even low-frequency variants are called reliably. The report separates constitutional findings from tumor-associated changes and summarizes each variant's contribution to overall risk.

Indications

Testing fits individuals with a family history of lung cancer, early-onset disease in relatives, or exposure backgrounds that compound genetic susceptibility. It also supports research and occupational-health programs that need to rank participants by risk. Results inform how intensively a person is surveilled rather than confirming an existing tumor.

Specimen & Reporting

Blood or saliva provides germline material, while a tumor sample is added when somatic context is needed. Reports return in about 7–10 working days with a clear risk-tier statement. Counselors can use the structured output to explain findings without overstating certainty.

Storage & Sourcing

DNA extracts are frozen and shipped on dry ice; collection kits are stable at ambient temperature before use. Population programs benefit from batched processing that lowers per-sample cost. Give Life Time International supplies collection materials and reorders so screening cohorts can be tested in waves. Clear participant instructions and pre-labeled kits reduce collection errors, which is important when many samples arrive from dispersed collection points at once.

FAQ

Q: Who should consider a 10-gene lung risk panel? People with a strong family history, early-onset disease among relatives, or combined genetic and environmental risk factors are the best-fit population.

Q: Does a positive result mean cancer is present? No. It indicates elevated susceptibility and supports closer surveillance, not a diagnosis of current malignancy.

Q: What sample is used for germline risk testing? Blood or saliva is typical for inherited variants, with tumor tissue added only when somatic context is also required.

Q: How are results used in a screening program? Participants are tiered by risk, which guides how early and how often imaging or clinical follow-up is offered.